BACKGROUND: Approximately 45% of nongonococcal urethritis cases have no identified etiology. Novel bacteria recently associated with bacterial vaginosis (BV) in women may be involved. We evaluated the association of idiopathic nongonococcal urethritis and 5 newly described BV-associated bacteria (BVAB). METHODS: Heterosexual men 16 years or older attending a sexually transmitted disease clinic in Seattle, Washington, from May 2007 to July 2011 and negative for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, and Ureaplasma urealyticum-biovar2 were eligible. Cases had urethral discharge or 5 or more polymorphonuclear leukocytes per high-power field in urethral exudates. Controls had no urethral discharge and less than 5 polymorphonuclear leukocytes per high-power field. Urine was tested for Atopobium spp., BVAB-2, BVAB-3, Megasphaera spp., and Leptotrichia/Sneathia spp. using quantitative taxon-directed polymerase chain reaction. RESULTS: Cases (n = 157) and controls (n = 102) were of similar age, education, and income, and most were white. Leptotrichia/Sneathia spp. was significantly associated with urethritis (24/157 [15.3%] vs. 6/102 [5.9%], P = 0.03). BVAB-2 was more common in cases than in controls (7/157 [4.5%] vs. 1/102 [1.0%], P = 0.15), and BVAB-3 (n = 2) and Megasphaera spp. (n = 1) were only detected in men with urethritis, but these bacteria were found only in men who also had Leptotrichia/Sneathia spp. Atopobium spp. was not associated with urethritis. The quantity of bacteria did not differ between cases and controls. Among treated cases, doxycycline was more effective than azithromycin for clinical cure of men with Leptotrichia/Sneathia spp. (9/10 vs. 7/12, P = 0.16) and BVAB-2 (3/3 vs. 0/3, P = 0.10). CONCLUSIONS: Leptotrichia/Sneathia spp. may be urethral pathogens or contribute to a pathogenic microbiota that can also include BVAB-2, BVAB-3, and Megasphaera spp. Doxycycline may be more effective than azithromycin against these newly identified bacteria.
BACKGROUND: Approximately 45% of nongonococcal urethritis cases have no identified etiology. Novel bacteria recently associated with bacterial vaginosis (BV) in women may be involved. We evaluated the association of idiopathic nongonococcal urethritis and 5 newly described BV-associated bacteria (BVAB). METHODS: Heterosexual men 16 years or older attending a sexually transmitted disease clinic in Seattle, Washington, from May 2007 to July 2011 and negative for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, and Ureaplasma urealyticum-biovar2 were eligible. Cases had urethral discharge or 5 or more polymorphonuclear leukocytes per high-power field in urethral exudates. Controls had no urethral discharge and less than 5 polymorphonuclear leukocytes per high-power field. Urine was tested for Atopobiumspp., BVAB-2, BVAB-3, Megasphaera spp., and Leptotrichia/Sneathiaspp. using quantitative taxon-directed polymerase chain reaction. RESULTS: Cases (n = 157) and controls (n = 102) were of similar age, education, and income, and most were white. Leptotrichia/Sneathiaspp. was significantly associated with urethritis (24/157 [15.3%] vs. 6/102 [5.9%], P = 0.03). BVAB-2 was more common in cases than in controls (7/157 [4.5%] vs. 1/102 [1.0%], P = 0.15), and BVAB-3 (n = 2) and Megasphaera spp. (n = 1) were only detected in men with urethritis, but these bacteria were found only in men who also had Leptotrichia/Sneathiaspp. Atopobiumspp. was not associated with urethritis. The quantity of bacteria did not differ between cases and controls. Among treated cases, doxycycline was more effective than azithromycin for clinical cure of men with Leptotrichia/Sneathiaspp. (9/10 vs. 7/12, P = 0.16) and BVAB-2 (3/3 vs. 0/3, P = 0.10). CONCLUSIONS:Leptotrichia/Sneathiaspp. may be urethral pathogens or contribute to a pathogenic microbiota that can also include BVAB-2, BVAB-3, and Megasphaera spp. Doxycycline may be more effective than azithromycin against these newly identified bacteria.
Authors: Jeanne M Marrazzo; Tina L Fiedler; Sujatha Srinivasan; Katherine K Thomas; Congzhou Liu; Daisy Ko; Hu Xie; Misty Saracino; David N Fredricks Journal: J Infect Dis Date: 2012-03-23 Impact factor: 5.226
Authors: Jeanne M Marrazzo; Laura A Koutsky; David A Eschenbach; Kathy Agnew; Kathleen Stine; Sharon L Hillier Journal: J Infect Dis Date: 2002-04-16 Impact factor: 5.226
Authors: W A Riemersma; C J C van der Schee; W I van der Meijden; H A Verbrugh; A van Belkum Journal: J Clin Microbiol Date: 2003-05 Impact factor: 5.948
Authors: Lisa E Manhart; Catherine W Gillespie; M Sylvan Lowens; Christine M Khosropour; Danny V Colombara; Matthew R Golden; Navneet R Hakhu; Katherine K Thomas; James P Hughes; Nicole L Jensen; Patricia A Totten Journal: Clin Infect Dis Date: 2012-12-07 Impact factor: 9.079
Authors: Emenike R K Eribe; Bruce J Paster; Dominique A Caugant; Floyd E Dewhirst; Verlyn K Stromberg; George H Lacy; Ingar Olsen Journal: Int J Syst Evol Microbiol Date: 2004-03 Impact factor: 2.747
Authors: Susan M Dutro; Jennifer K Hebb; Cresley A Garin; James P Hughes; George E Kenny; Patricia A Totten Journal: Sex Transm Dis Date: 2003-10 Impact factor: 2.830
Authors: Craig R Cohen; Jairam R Lingappa; Jared M Baeten; Musa O Ngayo; Carol A Spiegel; Ting Hong; Deborah Donnell; Connie Celum; Saidi Kapiga; Sinead Delany; Elizabeth A Bukusi Journal: PLoS Med Date: 2012-06-26 Impact factor: 11.069
Authors: Michael D Harwich; Myrna G Serrano; Jennifer M Fettweis; João M P Alves; Mark A Reimers; Gregory A Buck; Kimberly K Jefferson Journal: BMC Genomics Date: 2012-12-17 Impact factor: 3.969
Authors: Gabriella L Gentile; Amy Sanford Rupert; Lizette I Carrasco; Erin M Garcia; Naren Gajenthra Kumar; Scott W Walsh; Kimberly K Jefferson Journal: J Bacteriol Date: 2020-06-09 Impact factor: 3.490
Authors: Vinita S Rane; Christopher K Fairley; Ajith Weerakoon; Timothy H Read; Glenda Fehler; Marcus Y Chen; Catriona S Bradshaw Journal: J Clin Microbiol Date: 2014-06-04 Impact factor: 5.948
Authors: Linda M Gorgos; Laura K Sycuro; Sujatha Srinivasan; Tina L Fiedler; Martin T Morgan; Jennifer E Balkus; R Scott McClelland; David N Fredricks; Jeanne M Marrazzo Journal: Sex Transm Dis Date: 2015-09 Impact factor: 2.830
Authors: Laura C Chambers; Jennifer L Morgan; M Sylvan Lowens; Tashina S Robinson; Sarah S Romano; Gina L Leipertz; James P Hughes; Matthew R Golden; Christine M Khosropour; David N Fredricks; Lisa E Manhart Journal: Sex Transm Infect Date: 2018-09-04 Impact factor: 3.519
Authors: Marcus J Pond; Achyuta V Nori; Sheel Patel; Ken Laing; Margarita Ajayi; Andrew J Copas; Philip D Butcher; Phillip Hay; Syed Tariq Sadiq Journal: Sex Transm Infect Date: 2015-01-22 Impact factor: 3.519
Authors: Christine J Korhonen; Sujatha Srinivasan; Dandi Huang; Daisy L Ko; Eduard J Sanders; Norbert M Peshu; John N Krieger; Charles H Muller; Robert W Coombs; David N Fredricks; Susan M Graham Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731